We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IGX market cap is 41.92M. The company's latest EPS is USD -0.0568 and P/E is -10.21.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 742k | 1.54M | 1.54M | 950k | 1.04M |
| Operating Income | -9.55M | -6.26M | -7.98M | -9.41M | -9.49M |
| Net Income | -10.66M | -7.04M | -9.31M | -10.69M | -9.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.02M | 11.12M | 17.91M | 9.19M | 8.28M |
| Total Liabilities | 10.73M | 12.07M | 14.03M | 12.61M | 20.53M |
| Total Equity | 293k | -953k | 3.87M | -3.42M | -12.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.2M | -5.77M | -7.17M | -9.52M | -6.53M |
| Investing | 3.21M | -526k | -5.07M | 3.51M | 1.17M |
| Financing | -690k | 6.24M | 15.49M | 2.97M | 6.78M |
| Market Cap | 41.92M |
| Price to Earnings Ratio | -10.21 |
| Price to Sales Ratio | 98.31 |
| Price to Cash Ratio | 44.27 |
| Price to Book Ratio | -8.27 |
| Dividend Yield | - |
| Shares Outstanding | 174.65M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 29.73% |
| 52 Week High | 0.26 |
| 52 Week Low | 0.15 |
| Spread (Intraday) | 0.1 (66.67%) |
| Company Name | Intelgenx Technologies Corp |
| Address |
6420 abrams, ville saint laurent quebec city, quebec H4S 1Y2 |
| Website | https://www.intelgenx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
